Coronary in - stent restenosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) The condition meets the diagnostic criteria of both traditional Chinese medicine and Western medicine. (2) Meets the indications for PCI and consents to coronary stent implantation and is accompanied by mild angina pectoris (fewer than one attack per week). (3) Can cooperate to complete treatment and observation indicators. (4) Aged 18-85 years old with normal expressive and communicative abilities. (5) The patient is informed and voluntarily signs the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with chronic kidney disease and severe dysfunction of important organs such as the heart lungs and liver; those with severe primary diseases of the hematopoietic system and endocrine system malignant tumors etc. who are expected to be unable to complete the trial. (2) Patients with uncontrollable systemic infections. (3) Individuals who cannot cooperate with the study due to mental or psychological disorders. (4) Those who have participated in other clinical trials within the past 1 month. (5) Pregnant or planning to become pregnant and lactating women.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| The incidence of major adverse cardiac events (MACE);Electrocardiogram (ECG) echocardiography;Creatine phosphokinase isoenzyme (CK-MB) troponin myoglobin high-sensitivity C-reactive protein (hs-CRP) erythrocyte sedimentation rate (ESR);Cardiovascular clinical composite endpoints; | — |
Primary
| Measure | Time frame |
|---|---|
| The incidence and degree of in - stent restenosis in coronary arteries; | — |
Countries
China
Contacts
Guangdong Provincial Hospital of Chinese Medicine Zhuhai Hospital